Find research datasets worth reusing

Predicting Cerebrovascular Adverse Events Post Cardiac Surgery

ClinicalTrials.gov study NCT05786274. IPD Sharing: NO. Countries: 1. Publications: 0.

Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time

ClinicalTrials.gov study NCT07401303. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy i

ClinicalTrials.gov study NCT06236438. IPD Sharing: YES. Countries: 12. Publications: 0.

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

ClinicalTrials.gov study NCT07276997. IPD Sharing: YES. Countries: 1. Publications: 0.

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

ClinicalTrials.gov study NCT05618028. IPD Sharing: NO. Countries: 10. Publications: 0.

The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP Patients

ClinicalTrials.gov study NCT04933526. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical

ClinicalTrials.gov study NCT06318767. IPD Sharing: NO. Countries: 1. Publications: 0.

Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction

ClinicalTrials.gov study NCT07250152. IPD Sharing: NO. Countries: 1. Publications: 0.

Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) So

ClinicalTrials.gov study NCT04721015. IPD Sharing: NO. Countries: 8. Publications: 0.

Prediction Of Serious Adverse Event in Emergency Department With dysKAlemia, Retrospective Study

ClinicalTrials.gov study NCT05788523. IPD Sharing: NO. Countries: 1. Publications: 0.

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial C

ClinicalTrials.gov study NCT06632951. IPD Sharing: YES. Countries: 8. Publications: 0.

Sleep Disordered Breathing, Endothelial Function, and Adverse Events in Pregnancy

ClinicalTrials.gov study NCT05908591. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers

ClinicalTrials.gov study NCT04804254. IPD Sharing: NO. Countries: 3. Publications: 0.

Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer

ClinicalTrials.gov study NCT01613651. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens

ClinicalTrials.gov study NCT04895410. IPD Sharing: NO. Countries: 7. Publications: 0.

Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination

ClinicalTrials.gov study NCT06107413. IPD Sharing: YES. Countries: 8. Publications: 0.

Adverse Events in the Tracheal Intubation in the Intensive Care Unit

ClinicalTrials.gov study NCT03916224. IPD Sharing: YES. Countries: 1. Publications: 0.

Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma

ClinicalTrials.gov study NCT05714371. IPD Sharing: Not stated. Countries: 1. Publications: 0.

A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult Participants

ClinicalTrials.gov study NCT06774313. IPD Sharing: NO. Countries: 1. Publications: 0.

Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications

ClinicalTrials.gov study NCT04403087. IPD Sharing: NO. Countries: 1. Publications: 0.